Bluejay Diagnostics, Inc. Increase (Decrease) in Accrued Liabilities
Bluejay Diagnostics, Inc. (BJDX) reported Increase (Decrease) in Accrued Liabilities of $336.62 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-20.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2023-03-20
- Bluejay Diagnostics, Inc. increase (decrease) in accrued liabilities for the quarter ending 2022-12-31 was -$113.46K.
- Bluejay Diagnostics, Inc. increase (decrease) in accrued liabilities for the quarter ending 2022-09-30 was $207.14K, a 1.40% increase year-over-year.
- Bluejay Diagnostics, Inc. increase (decrease) in accrued liabilities for the quarter ending 2022-06-30 was $137.71K, a 99.94% increase year-over-year.
- Bluejay Diagnostics, Inc. increase (decrease) in accrued liabilities for the quarter ending 2022-03-31 was $105.22K, a 1213.97% increase year-over-year.
- Bluejay Diagnostics, Inc. increase (decrease) in accrued liabilities for fiscal 2022 was $336.62K, a 64.33% increase from fiscal 2021.
- Bluejay Diagnostics, Inc. increase (decrease) in accrued liabilities for fiscal 2021 was $204.84K, a 34.00% increase from fiscal 2020.
- Bluejay Diagnostics, Inc. increase (decrease) in accrued liabilities for fiscal 2020 was $152.87K.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2022-12-31 | -$113.46K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | $93.68K derived: sum of 2 quarters · filed 2023-03-20 | $231.40K derived: sum of 3 quarters · filed 2023-03-20 | $336.62K 10-K · filed 2023-03-20 |
| 2022-09-30 | $207.14K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $344.86K derived: sum of 2 quarters · filed 2022-11-09 | $450.08K 10-Q · filed 2022-11-09 | $373.75K derived: sum of 4 quarters · filed 2023-03-20 |
| 2022-06-30 | $137.71K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $242.94K 10-Q · filed 2022-08-10 | $166.61K derived: sum of 3 quarters · filed 2023-03-20 | $370.89K derived: sum of 4 quarters · filed 2023-03-20 |
| 2022-03-31 | $105.22K 10-Q · filed 2022-05-09 | $28.89K derived: sum of 2 quarters · filed 2023-03-20 | $233.18K derived: sum of 3 quarters · filed 2023-03-20 | $302.05K derived: sum of 4 quarters · filed 2023-03-20 |
| 2021-12-31 | -$76.33K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | $127.95K derived: sum of 2 quarters · filed 2023-03-20 | $196.83K derived: sum of 3 quarters · filed 2023-03-20 | $204.84K 10-K · filed 2023-03-20 |
| 2021-09-30 | $204.28K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $273.16K derived: sum of 2 quarters · filed 2022-11-09 | $281.17K 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $68.88K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $76.89K 10-Q · filed 2022-08-10 | ||
| 2021-03-31 | $8.01K 10-Q · filed 2022-05-09 | |||
| 2020-12-31 | $152.87K 10-K · filed 2022-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |